Literature DB >> 12585846

Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.

Richard B Resnick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12585846     DOI： 10.7326/0003-4819-138-4-200302180-00027

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  2 in total

Review 1.  Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.

Authors:  Jean Bonhomme; Ruth S Shim; Richard Gooden; Dawn Tyus; George Rust
Journal:  J Natl Med Assoc       Date:  2012 Jul-Aug       Impact factor: 1.798

2.  Effects of monoamine oxidase inhibitors on cocaine discrimination in rats.

Authors:  Michael B Gatch; Cynthia M Taylor; Elva Flores; Meghan Selvig; Michael J Forster
Journal:  Behav Pharmacol       Date:  2006-03       Impact factor: 2.293
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.